Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Scientific Reports|January 27, 2018
Development of novel fluorescent histamine H1-receptor antagonists to study ligand-binding kinetics in living cellsLeigh A Stoddart, Andrea J Vernall, Monica Bouzo-Lorenzo, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 15, 2024
Conformational dynamics underlying atypical chemokine receptor 3 activationOmolade Otun, Christelle Aljamous, Elise Del Nero, et al.
Biochemical Pharmacology|June 28, 2024
A high-affinity, cis-on photoswitchable beta blocker to optically control β2-adrenergic receptors in vitro and in vivoShuang Shi, Yang Zheng, Joëlle Goulding, et al.
Scientific Reports|May 29, 2019
Probe dependency in the determination of ligand binding kinetics at a prototypical G protein-coupled receptorReggie Bosma, Leigh A Stoddart, Victoria Georgi, et al.
Journal of Medicinal Chemistry|July 6, 2019
Route to Prolonged Residence Time at the Histamine H1 Receptor: Growing from Desloratadine to RupatadineReggie Bosma, Zhiyong Wang, Albert J Kooistra, et al.
Cell Reports Methods|April 14, 2023
NanoB2 to monitor interactions of ligands with membrane proteins by combining nanobodies and NanoBRETJelle van den Bor, Nick D Bergkamp, Stephanie M Anbuhl, et al.
Iscience|September 5, 2022
Optical control of the β2-adrenergic receptor with opto-prop-2: A cis-active azobenzene analog of propranololReggie Bosma, Nicola C Dijon, Yang Zheng, et al.
Molecular Pharmacology|November 29, 2025
Inhibition of constitutive activity of the atypical chemokine receptor 3 by the small-molecule inverse agonist VUF16840Reggie Bosma, Desislava Nesheva, Merel Rijnsburger, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 11, 2025
Disruption of constitutive CXCR4 oligomers impairs oncogenic properties in lymphoid neoplasmsSimon Mobach, Nick D Bergkamp, Ziliang Ma, et al.
Molecular Pharmacology|February 12, 2024
Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3Aurelien M Zarca, Ilze Adlere, Cristina P Viciano, et al.
Pageof 3